|

KLH-2109 Placebo + Leurprorelin acetate Clinical Trials

1 actively recruiting trial

Also known as: KLH-2019 Placebo + Leurprorelin acetate Placebo

Pipeline

Phase 3: 1

Top Sponsors

  • JW Pharmaceutical1

Indications

  • Menorrhagia1
  • Uterine Fibroids1
  • Cancer1

Other1 trial

to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.